Oral Anti-Amyloid Shows Disease-Modifying Potential ...Middle East

Use of ALZ-801, an optimized prodrug of tramiprosate, led to a significant reduction of plasma p-tau181, slowing of hippocampal atrophy, and stabilization of cognition in a phase 2 trial. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Oral Anti-Amyloid Shows Disease-Modifying Potential )

Also on site :

• Brynn Whitfield Announces Exit From 'RHONY' After Two Seasons
• Pop Princess Covers Classic ‘70s Rock Hit: ‘This Is So Good’
• Born on One of These 4 Dates? You're a Wise, Old Soul